ArticleOncology letters2022

Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios are associated with the efficacy of immunotherapy in stage III/IV non-small cell lung cancer.

Xiaojuan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.